$1.35 Billion is the total value of Perceptive Advisors's 155 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 55.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FOLD | Sell | AMICUS THERAPEUTICS INC | $147,823,000 | -57.9% | 15,239,444 | -47.2% | 10.94% | -22.1% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $141,208,000 | -39.7% | 2,496,167 | -57.6% | 10.45% | +11.6% |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $86,455,000 | -51.7% | 2,240,928 | -59.8% | 6.40% | -10.5% |
| DYAX | Sell | DYAX CORP | $68,439,000 | +8.9% | 1,819,215 | -44.7% | 5.06% | +101.6% |
| TSRO | Sell | TESARO INC | $50,680,000 | -35.6% | 968,659 | -50.7% | 3.75% | +19.2% |
| RTRX | Sell | RETROPHIN INC | $49,756,000 | -53.6% | 2,579,380 | -51.3% | 3.68% | -14.1% |
| AGN | New | ALLERGAN PLC | $45,313,000 | – | 145,000 | +100.0% | 3.35% | – |
| GBT | Sell | GLOBAL BLOOD THERAPEUTICS IN | $38,363,000 | -50.6% | 1,186,630 | -35.6% | 2.84% | -8.6% |
| NVRO | Sell | NEVRO CORP | $32,694,000 | -41.9% | 484,279 | -60.1% | 2.42% | +7.6% |
| TEVA | Buy | TEVA PHARMACEUTICAL INDS LTDadr | $31,573,000 | +74.7% | 481,000 | +50.3% | 2.34% | +223.5% |
| VSAR | Sell | VERSARTIS INC | $28,490,000 | -46.7% | 2,299,454 | -50.4% | 2.11% | -1.3% |
| GWPH | Sell | GW PHARMACEUTICALS -ADRput | $27,776,000 | -49.3% | 400,000 | -33.3% | 2.06% | -6.2% |
| XNCR | Sell | XENCOR INC | $27,117,000 | -36.8% | 1,854,784 | -47.2% | 2.01% | +17.0% |
| RXDX | Sell | IGNYTA INC | $24,282,000 | -28.4% | 1,812,060 | -53.1% | 1.80% | +32.6% |
| LBIO | Sell | LION BIOTECHNOLOGIES INC | $23,161,000 | -32.0% | 3,000,161 | -49.2% | 1.71% | +26.0% |
| ACRX | Sell | ACELRX PHARMACEUTICALS INC | $23,084,000 | -39.6% | 5,995,760 | -52.1% | 1.71% | +11.9% |
| SRPT | Sell | Sarepta Therapeutics Inccall | $19,290,000 | +0.1% | 500,000 | -16.7% | 1.43% | +85.3% |
| Buy | BAXTER INTL INC | $18,503,000 | +369.4% | 485,000 | +304.2% | 1.37% | +772.0% | |
| FPRX | Sell | FIVE PRIME THERAPEUTICS INC | $18,016,000 | +106.0% | 434,129 | -23.6% | 1.33% | +281.9% |
| AGTC | Sell | APPLIED GENETIC TECHNOL CORP | $17,575,000 | +57.2% | 861,513 | -49.4% | 1.30% | +190.8% |
| LJPC | Sell | LA JOLLA PHARMACEUTICAL CO | $17,537,000 | -51.8% | 649,515 | -50.4% | 1.30% | -10.7% |
| DERM | Sell | DERMIRA INC | $17,374,000 | -21.1% | 502,000 | -46.8% | 1.28% | +46.0% |
| QURE | Sell | UNIQURE NV | $15,996,000 | -43.3% | 967,093 | -29.9% | 1.18% | +4.9% |
| QTNT | Sell | QUOTIENT LTD | $14,297,000 | -30.9% | 893,540 | -42.5% | 1.06% | +27.9% |
| VRTX | New | VERTEX PHARMACEUTICALS INC | $13,841,000 | – | 110,000 | +100.0% | 1.02% | – |
| XLRN | Sell | ACCELERON PHARMA INC | $13,460,000 | -2.1% | 276,036 | -50.0% | 1.00% | +81.4% |
| CTMX | New | CYTOMX THERAPEUTICS INC | $13,399,000 | – | 642,047 | +100.0% | 0.99% | – |
| RGNX | Sell | REGENXBIO INC | $12,934,000 | -62.3% | 779,213 | -50.0% | 0.96% | -30.2% |
| CDTX | Sell | CIDARA THERAPEUTICS INC | $12,747,000 | -32.5% | 742,858 | -50.0% | 0.94% | +24.9% |
| PFNX | Sell | PFENEX INC | $11,896,000 | -59.2% | 960,877 | -50.5% | 0.88% | -24.5% |
| EGRX | Sell | EAGLE PHARMACEUTICALS INC | $11,806,000 | -35.2% | 133,145 | -45.9% | 0.87% | +19.9% |
| DBVT | Sell | DBV TECHNOLOGIES S Asponsored adr | $11,137,000 | -49.0% | 306,715 | -50.0% | 0.82% | -5.5% |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $10,652,000 | -38.3% | 404,404 | -50.0% | 0.79% | +14.2% |
| CSU | Sell | CAPITAL SR LIVING CORP | $10,090,000 | -54.5% | 483,700 | -56.3% | 0.75% | -15.8% |
| AXGT | Sell | AXOVANT SCIENCES LTD | $9,646,000 | -8.9% | 535,000 | -34.8% | 0.71% | +68.8% |
| DEPO | New | DEPOMED INC | $9,065,000 | – | 500,000 | +100.0% | 0.67% | – |
| Sell | ACADIA PHARMACEUTICALS INC | $8,743,000 | -55.2% | 245,240 | -58.5% | 0.65% | -17.1% | |
| Sell | BELLICUM PHARMACEUTICALS | $8,537,000 | -43.6% | 421,188 | -59.6% | 0.63% | +4.5% | |
| ALDX | Sell | ALDEYRA THERAPEUTICS INC | $8,410,000 | -24.6% | 1,240,458 | -35.2% | 0.62% | +39.5% |
| Buy | AMGEN INC | $8,117,000 | +2192.9% | 50,000 | +1853.1% | 0.60% | +4192.9% | |
| VBIV | Sell | VBI VACCINES | $7,955,000 | -53.8% | 3,260,356 | -50.0% | 0.59% | -14.4% |
| ONTY | Sell | ONCOTHYREON INC | $7,579,000 | +174.6% | 3,414,121 | -51.9% | 0.56% | +410.0% |
| Sell | ANI PHARMACEUTICALS INCnote 3.000%12/0 | $7,461,000 | -46.1% | 7,500,000 | -50.0% | 0.55% | -0.2% | |
| MYOK | New | MYOKARDIA INC | $7,372,000 | – | 502,903 | +100.0% | 0.54% | – |
| NEPT | Sell | NEPTUNE TECHNOLOGIES BIORESO | $7,169,000 | -51.4% | 6,700,444 | -50.0% | 0.53% | -10.0% |
| ADHD | New | ALCOBRA LTD | $6,458,000 | – | 1,028,272 | +100.0% | 0.48% | – |
| AFMD | Sell | AFFIMED N V | $6,186,000 | -42.3% | 868,820 | -50.0% | 0.46% | +7.0% |
| Sell | ASSEMBLY BIOSCIENCES INC | $5,970,000 | -60.7% | 795,000 | -50.0% | 0.44% | -27.2% | |
| ABEO | Sell | ABEONA THERAPEUTICS INC | $5,923,000 | -58.5% | 1,762,881 | -50.0% | 0.44% | -23.3% |
| Sell | ARDELYX INC | $5,725,000 | -47.6% | 315,955 | -50.0% | 0.42% | -2.8% | |
| OTIC | Sell | OTONOMY INC | $5,716,000 | +685.2% | 205,986 | -44.4% | 0.42% | +1358.6% |
| ZYNE | Sell | ZYNERBA PHARMACEUTICALS INC | $5,623,000 | -66.1% | 558,446 | -51.8% | 0.42% | -37.2% |
| NERV | Sell | MINERVA NEUROSCIENCES | $4,919,000 | -42.2% | 810,537 | -50.0% | 0.36% | +7.1% |
| ANTH | Sell | ANTHERA PHARMACEUTICALS INC | $4,604,000 | -55.8% | 992,156 | -50.0% | 0.34% | -18.0% |
| Sell | NEURODERM LTD | $4,604,000 | -58.8% | 270,000 | -50.0% | 0.34% | -23.5% | |
| PRTO | Sell | PROTEON THERAPEUTICS INC | $4,265,000 | -44.2% | 275,000 | -50.0% | 0.32% | +3.3% |
| TRXC | Sell | TRANSENTERIX INC | $4,256,000 | -48.4% | 1,715,941 | -53.0% | 0.32% | -4.5% |
| TKAI | Sell | TOKAI PHARMACEUTICALS INC | $4,232,000 | -57.9% | 485,338 | -50.0% | 0.31% | -21.9% |
| Sell | ALLIQUA BIOMEDICAL INC | $4,112,000 | -66.3% | 1,921,951 | -50.0% | 0.30% | -37.6% | |
| SPNC | New | SPECTRANETICS CORP | $4,060,000 | – | 269,570 | +100.0% | 0.30% | – |
| SRPT | New | Sarepta Therapeutics Incput | $3,858,000 | – | 100,000 | +100.0% | 0.28% | – |
| New | BAXTER INTERNATIONAL INCcall | $3,815,000 | – | 100,000 | +100.0% | 0.28% | – | |
| VTAE | Sell | VITAE PHARMACEUTICALS INC | $3,620,000 | -17.8% | 200,000 | -50.0% | 0.27% | +52.3% |
| AKBA | Sell | AKEBIA THERAPEUTICS INC | $3,359,000 | -33.1% | 260,000 | -50.0% | 0.25% | +23.9% |
| WBA | Sell | WALGREENS BOOTS ALLIANCE INC | $3,005,000 | -48.8% | 35,292 | -50.0% | 0.22% | -5.1% |
| ELGX | Buy | ENDOLOGIX INC | $2,970,000 | +1991.5% | 300,000 | +2506.4% | 0.22% | +3566.7% |
| CI | Sell | CIGNA CORPORATION | $2,927,000 | -44.3% | 20,000 | -48.6% | 0.22% | +3.3% |
| MDCO | New | MEDICINES CO | $2,801,000 | – | 75,000 | +100.0% | 0.21% | – |
| HEWG | Sell | ISHARES TRhdg msci germn | $2,437,000 | -63.0% | 100,000 | -65.5% | 0.18% | -31.6% |
| TTNP | New | TITAN PHARMACEUTICALS INC DE | $2,321,000 | – | 522,728 | +100.0% | 0.17% | – |
| MGCD | Sell | MGC DIAGNOSTICS CORP | $2,213,000 | -50.1% | 336,287 | -50.0% | 0.16% | -7.3% |
| CPRX | Sell | CATALYST PHARMACEUTICALS INC | $2,085,000 | -59.2% | 851,200 | -50.0% | 0.15% | -24.5% |
| CRBP | Sell | CORBUS PHARMACEUTICALS INC | $2,062,000 | -47.5% | 1,250,000 | -50.0% | 0.15% | -2.5% |
| NEOS | Sell | NEOS THERAPEUTICS INC | $2,042,000 | -86.9% | 142,603 | -80.8% | 0.15% | -75.8% |
| PSDV | Sell | PSIVIDA CORP | $2,000,000 | +289.1% | 415,000 | -34.1% | 0.15% | +604.8% |
| DSCI | Sell | DERMA SCIENCES INC | $1,841,000 | -45.8% | 402,884 | -44.1% | 0.14% | 0.0% |
| EVH | Sell | EVOLENT HEALTH INCcl a | $1,787,000 | -59.2% | 147,600 | -46.2% | 0.13% | -24.6% |
| ABEOW | Sell | ABEONA THERAPEUTICS INC*w exp 12/19/201 | $1,656,000 | -61.9% | 1,259,636 | -50.0% | 0.12% | -29.3% |
| XENE | Sell | XENON PHARMACEUTICALS INC | $1,655,000 | -51.3% | 205,800 | -50.0% | 0.12% | -10.3% |
| Sell | INTEC PHARMA LTD JERUSALEM | $1,474,000 | -62.4% | 275,000 | -60.7% | 0.11% | -30.6% | |
| CSBR | Sell | CHAMPIONS ONCOLOGY INC | $1,330,000 | -66.6% | 372,597 | -50.0% | 0.10% | -38.4% |
| Sell | ARNO THERAPEUTICS INC | $1,194,000 | -16.2% | 3,463,292 | -14.9% | 0.09% | +54.4% | |
| NVTA | Sell | INVITAE CORP | $1,177,000 | -51.6% | 143,366 | -57.4% | 0.09% | -10.3% |
| SAGE | Sell | SAGE THERAPEUTICS INC | $1,166,000 | -31.2% | 20,000 | -50.0% | 0.09% | +26.5% |
| BCLI | New | BRAINSTORM CELL THERAPEUTICS | $1,144,000 | – | 400,000 | +100.0% | 0.08% | – |
| GNVC | Sell | GENVEC INC | $1,133,000 | -60.2% | 615,844 | -50.0% | 0.08% | -26.3% |
| SCYX | Sell | SCYNEXIS INC | $1,087,000 | -57.3% | 175,000 | -50.0% | 0.08% | -21.6% |
| NVLS | Sell | NIVALIS THERAPEUTICS INC | $968,000 | -70.1% | 125,000 | -50.0% | 0.07% | -44.6% |
| FCAU | Sell | FIAT CHRYSLER AUTOMOBILES N | $867,000 | -47.1% | 62,000 | -50.0% | 0.06% | -1.5% |
| CGNT | Sell | COGENTIX MED INC | $869,000 | -48.0% | 673,257 | -50.0% | 0.06% | -4.5% |
| VCEL | Sell | VERICEL CORP | $789,000 | -58.6% | 305,662 | -56.5% | 0.06% | -23.7% |
| AQXP | Sell | AQUINOX PHARMACEUTICALS INC | $744,000 | -55.7% | 59,600 | -50.0% | 0.06% | -17.9% |
| VNDA | New | VANDA PHARMACEUTICALS INC | $669,000 | – | 71,849 | +100.0% | 0.05% | – |
| XIV | Sell | CREDIT SUISSE NASSAU BRHinvrs vix sterm | $645,000 | -71.5% | 25,000 | -73.1% | 0.05% | -46.7% |
| IMMU | New | IMMUNOMEDICS INC | $614,000 | – | 200,000 | +100.0% | 0.04% | – |
| ACST | New | ACASTI PHARMA INCcl a new | $594,000 | – | 236,559 | +100.0% | 0.04% | – |
| DRNA | Sell | DICERNA PHARMACEUTICALS INC | $594,000 | -27.7% | 50,000 | -50.0% | 0.04% | +33.3% |
| ANIP | Sell | ANI PHARMACEUTICALS INC | $578,000 | -62.0% | 12,800 | -66.8% | 0.04% | -29.5% |
| GLMD | Sell | GALMED PHARMACEUTICALS LTD | $571,000 | -48.7% | 75,000 | -50.0% | 0.04% | -6.7% |
| NVO | Sell | NOVO-NORDISK A Sadr | $554,000 | -4.5% | 9,540 | -10.7% | 0.04% | +78.3% |
| STML | Sell | STEMLINE THERAPEUTICS INC | $496,000 | -64.3% | 78,603 | -50.0% | 0.04% | -32.7% |
| Sell | AVINGER INC | $444,000 | -84.5% | 19,566 | -90.0% | 0.03% | -71.3% | |
| MACK | New | MERRIMACK PHARMACEUTICALS IN | $395,000 | – | 50,000 | +100.0% | 0.03% | – |
| Sell | TRILLIUM THERAPEUTICS INC | $378,000 | -51.7% | 30,000 | -50.0% | 0.03% | -9.7% | |
| BVX | Sell | BOVIE MEDICAL CORP | $342,000 | -46.9% | 162,700 | -50.0% | 0.02% | -3.8% |
| Sell | ACHAOGEN INC | $344,000 | -50.3% | 60,000 | -50.0% | 0.02% | -10.7% | |
| ARIA | Sell | ARIAD PHARMACEUTICALS INC | $313,000 | -94.0% | 50,000 | -94.4% | 0.02% | -89.0% |
| CRIS | Sell | CURIS INC | $291,000 | -28.0% | 100,000 | -50.0% | 0.02% | +37.5% |
| APHB | Sell | AMPLIPHI BIOSCIENCES CORP | $298,000 | -52.8% | 74,800 | -53.2% | 0.02% | -12.0% |
| TNDM | New | TANDEM DIABETES CARE INC | $295,000 | – | 25,000 | +100.0% | 0.02% | – |
| CRL | New | CHARLES RIV LABS INTL INC | $274,000 | – | 3,410 | +100.0% | 0.02% | – |
| GTS | Sell | TRIPLE-S MGMT CORPcl b | $254,000 | -32.8% | 10,605 | -50.0% | 0.02% | +26.7% |
| HNT | Sell | HEALTH NET INC | $262,000 | -43.3% | 3,831 | -50.0% | 0.02% | +5.6% |
| GILD | Sell | GILEAD SCIENCES INC | $249,000 | -48.3% | 2,457 | -50.0% | 0.02% | -5.3% |
| PMC | Sell | PHARMERICA CORP | $238,000 | -38.7% | 6,800 | -50.0% | 0.02% | +12.5% |
| GB | Sell | GREATBATCH INC | $231,000 | -53.4% | 4,391 | -50.0% | 0.02% | -15.0% |
| CRVL | New | CORVEL CORP | $225,000 | – | 5,115 | +100.0% | 0.02% | – |
| TARO | Sell | TARO PHARMACEUTICAL INDS LTD | $231,000 | -45.8% | 1,493 | -50.0% | 0.02% | 0.0% |
| MCK | New | MCKESSON CORP | $233,000 | – | 1,179 | +100.0% | 0.02% | – |
| CBM | Sell | CAMBREX CORP | $221,000 | -40.6% | 4,692 | -50.0% | 0.02% | +6.7% |
| ABC | New | AMERISOURCEBERGEN CORP | $211,000 | – | 2,030 | +100.0% | 0.02% | – |
| LPNT | Sell | LIFEPOINT HEALTH INC | $210,000 | -41.3% | 2,862 | -43.3% | 0.02% | +14.3% |
| THC | New | TENET HEALTHCARE CORP | $210,000 | – | 6,927 | +100.0% | 0.02% | – |
| ENSG | New | ENSIGN GROUP INC | $198,000 | – | 8,744 | +100.0% | 0.02% | – |
| MGLN | Sell | MAGELLAN HEALTH INC | $207,000 | -45.2% | 3,351 | -50.9% | 0.02% | 0.0% |
| BIIB | New | BIOGEN INC | $199,000 | – | 648 | +100.0% | 0.02% | – |
| SCAI | New | SURGICAL CARE AFFILIATES INC | $204,000 | – | 5,133 | +100.0% | 0.02% | – |
| WOOF | New | VCA INC | $205,000 | – | 3,731 | +100.0% | 0.02% | – |
| New | ALMOST FAMILY INC | $187,000 | – | 4,889 | +100.0% | 0.01% | – | |
| Q | New | QUINTILES TRANSNATIO HLDGS I | $185,000 | – | 2,698 | +100.0% | 0.01% | – |
| UNH | New | UNITEDHEALTH GROUP INC | $193,000 | – | 1,640 | +100.0% | 0.01% | – |
| New | AMEDISYS INC | $183,000 | – | 4,648 | +100.0% | 0.01% | – | |
| EXAC | New | EXACTECH INC | $195,000 | – | 10,734 | +100.0% | 0.01% | – |
| NK | New | NANTKWEST INC | $173,000 | – | 10,000 | +100.0% | 0.01% | – |
| CYH | New | COMMUNITY HEALTH SYS INC NEW | $178,000 | – | 6,724 | +100.0% | 0.01% | – |
| CNC | New | CENTENE CORP DEL | $171,000 | – | 2,593 | +100.0% | 0.01% | – |
| ICLR | Sell | ICON PLC | $172,000 | -54.0% | 2,213 | -57.9% | 0.01% | -13.3% |
| AMSG | New | AMSURG CORP | $170,000 | – | 2,243 | +100.0% | 0.01% | – |
| MOH | Sell | MOLINA HEALTHCARE INC | $168,000 | -57.8% | 2,800 | -51.5% | 0.01% | -25.0% |
| INFI | Sell | INFINITY PHARMACEUTICALS INC | $157,000 | -53.6% | 20,000 | -50.0% | 0.01% | -14.3% |
| LHCG | Sell | LHC GROUP INC | $168,000 | -68.3% | 3,705 | -68.7% | 0.01% | -42.9% |
| LCI | Sell | LANNET INC | $168,000 | -50.0% | 4,182 | -48.3% | 0.01% | -7.7% |
| DRAD | New | DIGIRAD CORP | $145,000 | – | 24,988 | +100.0% | 0.01% | – |
| FONR | New | FONAR CORP | $146,000 | – | 8,473 | +100.0% | 0.01% | – |
| LNTH | New | LANTHEUS HLDGS INC | $131,000 | – | 38,784 | +100.0% | 0.01% | – |
| MYGN | Sell | MYRIAD GENETICS INC | $108,000 | -42.6% | 2,500 | -50.0% | 0.01% | 0.0% |
| UTMD | New | UTAH MED PRODS INC | $107,000 | – | 1,828 | +100.0% | 0.01% | – |
| CLLS | Sell | CELLECTIS S Asponsored ads | $93,000 | -99.2% | 2,996 | -99.3% | 0.01% | -98.5% |
| NSPH | Sell | NANOSPHERE INC | $22,000 | -81.0% | 35,379 | -50.0% | 0.00% | -60.0% |
| SCMP | Sell | SUCAMPO PHARMACEUTICALS INCcl a | $13,000 | -95.9% | 759 | -95.2% | 0.00% | -92.3% |
| CAPR | Sell | CAPRICOR THERAPEUTICS INC | $12,000 | -62.5% | 4,000 | -50.0% | 0.00% | 0.0% |
| AXDX | New | ACCELERATE DIAGNOSTICS INC | $16,000 | – | 750 | +100.0% | 0.00% | – |
| IDRA | Buy | IDERA PHARMACEUTICALS INC | $14,000 | +40.0% | 4,578 | +48.9% | 0.00% | – |
| CNAT | Exit | CONATUS PHARMACEUTICALS INC | $0 | – | -850 | -100.0% | 0.00% | – |
| INGN | New | INOGEN INC | $5,000 | – | 125 | +100.0% | 0.00% | – |
| XBI | Exit | STREETTRACKS SPDR BIOTEC ETFcall | $0 | – | -200 | -100.0% | 0.00% | – |
| FLKS | New | FLEX PHARMA INC | $3,000 | – | 237 | +100.0% | 0.00% | – |
| VRX | Exit | VALEANT PHARMACEUTICALS INTERNATIONAL INcall | $0 | – | -200 | -100.0% | -0.00% | – |
| NUVA | Exit | NUVASIVE INC | $0 | – | -504 | -100.0% | -0.00% | – |
| JNP | Exit | JUNIPER PHARMACEUTICALS INC | $0 | – | -3,472 | -100.0% | -0.00% | – |
| AMAG | Exit | AMAG PHARMACEUTICALS INC | $0 | – | -5,808 | -100.0% | -0.01% | – |
| DVCR | Exit | DIVERSICARE HEALTHCARE SVCS | $0 | – | -24,674 | -100.0% | -0.01% | – |
| REPH | Exit | RECRO PHARMA INC | $0 | – | -24,126 | -100.0% | -0.01% | – |
| WCG | Exit | WELLCARE HEALTH PLANS INC | $0 | – | -4,378 | -100.0% | -0.02% | – |
| CNCE | Exit | CONCERT PHARMACEUTICALS INC | $0 | – | -20,758 | -100.0% | -0.02% | – |
| HCA | Exit | HCA HOLDINGS INC | $0 | – | -5,126 | -100.0% | -0.02% | – |
| CAH | Exit | CARDINAL HEALTH INC | $0 | – | -5,148 | -100.0% | -0.02% | – |
| Exit | ANTHEM INC | $0 | – | -2,872 | -100.0% | -0.02% | – | |
| EW | Exit | EDWARDS LIFESCIENCES CORP | $0 | – | -3,000 | -100.0% | -0.02% | – |
| Exit | ADDUS HOMECARE CORP | $0 | – | -15,202 | -100.0% | -0.02% | – | |
| INCR | Exit | INC RESH HLDGS INCcl a | $0 | – | -14,522 | -100.0% | -0.02% | – |
| AET | Exit | AETNA INC NEW | $0 | – | -5,172 | -100.0% | -0.02% | – |
| QTNTW | Exit | QUOTIENT LTD*w exp 10/30/201 | $0 | – | -262,502 | -100.0% | -0.04% | – |
| TBT | Exit | PROSHARES TR | $0 | – | -24,000 | -100.0% | -0.04% | – |
| SNSS | Exit | SUNESIS PHARMACEUTICALS INC | $0 | – | -1,400,000 | -100.0% | -0.04% | – |
| XNCR | Exit | XENCOR INCput | $0 | – | -100,000 | -100.0% | -0.05% | – |
| ACST | Exit | ACASTI PHARMA INC | $0 | – | -4,731,200 | -100.0% | -0.05% | – |
| IRWD | Exit | IRONWOOD PHARMACEUTICALS INC | $0 | – | -172,458 | -100.0% | -0.07% | – |
| BCLI | Exit | BRAINSTORM CELL THERAPEUTICS | $0 | – | -800,000 | -100.0% | -0.07% | – |
| SGYPQ | Exit | SYNERGY PHARMACEUTICALS DEL | $0 | – | -452,000 | -100.0% | -0.10% | – |
| UUP | Exit | POWERSHS DB US DOLLAR INDEXdoll indx bull | $0 | – | -110,000 | -100.0% | -0.11% | – |
| BCRX | Exit | BIOCRYST PHARMACEUTICALS | $0 | – | -247,490 | -100.0% | -0.11% | – |
| RPRX | Exit | REPROS THERAPEUTICS INC | $0 | – | -440,000 | -100.0% | -0.13% | – |
| PTCT | Exit | PTC THERAPEUTICS INCcall | $0 | – | -200,000 | -100.0% | -0.21% | – |
| RGEN | Exit | REPLIGEN CORPput | $0 | – | -200,000 | -100.0% | -0.22% | – |
| CYAD | Exit | CELYAD SAadr | $0 | – | -150,000 | -100.0% | -0.25% | – |
| STJ | Exit | ST JUDE MED INC | $0 | – | -103,040 | -100.0% | -0.26% | – |
| RLYP | Exit | RELYPSA INCput | $0 | – | -500,000 | -100.0% | -0.37% | – |
| THOR | Exit | THORATEC CORP | $0 | – | -172,000 | -100.0% | -0.44% | – |
| RLYP | Exit | RELYPSA INCcall | $0 | – | -600,000 | -100.0% | -0.44% | – |
| THOR | Exit | THORATEC CORPcall | $0 | – | -200,000 | -100.0% | -0.51% | – |
| SHPG | Exit | SHIRE PLCsponsored adr | $0 | – | -82,000 | -100.0% | -0.67% | – |
| GILD | Exit | GILEAD SCIENCES INCput | $0 | – | -200,000 | -100.0% | -0.78% | – |
| NVO | Exit | NOVO-NORDISK A/S-SPONS ADRput | $0 | – | -400,000 | -100.0% | -0.87% | – |
| SSO | Exit | PROSHARES ULTRA S & P500put | $0 | – | -400,000 | -100.0% | -0.89% | – |
| CEMP | Exit | CEMPRA INC | $0 | – | -1,165,000 | -100.0% | -1.30% | – |
| XBI | Exit | STREETTRACKS SPDR BIOTEC ETFput | $0 | – | -550,000 | -100.0% | -1.37% | – |
| RLYP | Exit | RELYPSA INC | $0 | – | -1,975,884 | -100.0% | -1.46% | – |
| IWM | Exit | ISHARES RUSSELL 2000put | $0 | – | -400,000 | -100.0% | -1.74% | – |
| PTCT | Exit | PTC THERAPEUTICS INCput | $0 | – | -2,010,000 | -100.0% | -2.14% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-02-16
About Perceptive Advisors
Perceptive Advisors is a New York-based hedge fund that specializes in healthcare investments. The company was founded in 1999 by Joseph Edelman, who serves as the CEO and Chief Investment Officer. Since its inception, Perceptive Advisors has become one of the most successful healthcare-focused hedge funds in the world, with over $5 billion in assets under management.
The company's investment strategy is based on a deep understanding of the healthcare industry and a focus on identifying promising companies with innovative products and technologies. Perceptive Advisors invests in a wide range of healthcare sectors, including biotechnology, pharmaceuticals, medical devices, and healthcare services.
One of the key factors behind Perceptive Advisors' success is its team of experienced professionals. In addition to Joseph Edelman, the company's leadership team includes Adam Stone, the COO, and Jeremy Goldberg, the Chief Scientific Officer. The team also includes a group of highly skilled analysts and researchers who are experts in their respective fields.
Perceptive Advisors has a strong track record of generating high returns for its investors. However, it is important to note that investing in hedge funds carries significant risks, and investors should carefully consider their investment objectives and risk tolerance before investing. As with any investment, it is important to conduct thorough research and seek the advice of a qualified financial advisor before making any investment decisions.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES SHARES | 42 | Q3 2023 | 15.7% |
| AMICUS THERAPEUTICS SHARES | 39 | Q3 2023 | 14.0% |
| ALDEYRA THERAPEUTICS SHARES | 35 | Q3 2023 | 3.3% |
| QUOTIENT TECHNOLOGY INC | 34 | Q3 2022 | 2.7% |
| GLOBAL BLOOD THERAPEUTICS SHARES | 29 | Q3 2022 | 9.3% |
| ADMA BIOLOGICS SHARES | 29 | Q3 2023 | 1.4% |
| RETROPHIN SHARES | 28 | Q3 2020 | 5.5% |
| DBV TECHNOLOGIES SA-SPON ADR | 28 | Q3 2021 | 1.8% |
| VBI VACCINES SHARES | 27 | Q1 2023 | 2.8% |
| IOVANCE BIOTHERAPEUTICS INC | 26 | Q3 2023 | 9.1% |
View Perceptive Advisors's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CHEMBIO DIAGNOSTICS, INC.Sold out | May 04, 2023 | 0 | 0.0% |
| VBI Vaccines Inc/BC | April 07, 2023 | 43,509,553 | 16.7% |
| Landos Biopharma, Inc. | March 30, 2023 | 14,869,915 | 47.7% |
| REATA PHARMACEUTICALS INC | March 07, 2023 | 2,083,799 | 6.5% |
| AGILE THERAPEUTICS INCSold out | February 14, 2023 | 0 | 0.0% |
| ALBIREO PHARMA, INC. | February 14, 2023 | 1,757,160 | 8.5% |
| BELLUS Health Inc. | February 14, 2023 | 8,891,027 | 7.1% |
| CinCor Pharma, Inc. | February 14, 2023 | 2,576,325 | 5.9% |
| Coherus BioSciences, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| CONCERT PHARMACEUTICALS, INC. | February 14, 2023 | 1,800,000 | 3.6% |
View Perceptive Advisors's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-17 |
| SC 13D/A | 2024-04-17 |
| 4 | 2024-04-15 |
| SC 13G/A | 2024-04-15 |
| SC 13G | 2024-04-15 |
| SC 13D/A | 2024-04-10 |
| 4 | 2024-04-08 |
| 4 | 2024-04-03 |
| SC 13D/A | 2024-04-03 |
| SC 13D | 2024-03-20 |
View Perceptive Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.